Is HPOL B undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
6/6
Valuation Score 6/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of HPOL B when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: HPOL B (SEK103) is trading below our estimate of fair value (SEK174.52)
Significantly Below Fair Value: HPOL B is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for HPOL B?
Key metric: As HPOL B is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for HPOL B. This is calculated by dividing HPOL B's market cap by their current
earnings.
What is HPOL B's PE Ratio?
PE Ratio
14.9x
Earnings
SEK 2.37b
Market Cap
SEK 35.48b
HPOL B key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: HPOL B is good value based on its Price-To-Earnings Ratio (14.9x) compared to the European Chemicals industry average (17.9x).
Price to Earnings Ratio vs Fair Ratio
What is HPOL B's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
HPOL B PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
14.9x
Fair PE Ratio
15.9x
Price-To-Earnings vs Fair Ratio: HPOL B is good value based on its Price-To-Earnings Ratio (14.9x) compared to the estimated Fair Price-To-Earnings Ratio (15.9x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst HPOL B forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
SEK 103.00
SEK 125.67
+22.0%
8.7%
SEK 145.00
SEK 114.00
n/a
6
Nov ’25
SEK 103.00
SEK 128.00
+24.3%
7.8%
SEK 145.00
SEK 114.00
n/a
6
Oct ’25
SEK 105.60
SEK 134.60
+27.5%
7.7%
SEK 147.00
SEK 119.00
n/a
5
Sep ’25
SEK 115.80
SEK 136.33
+17.7%
7.5%
SEK 147.00
SEK 119.00
n/a
6
Aug ’25
SEK 116.30
SEK 138.00
+18.7%
5.6%
SEK 147.00
SEK 129.00
n/a
6
Jul ’25
SEK 119.80
SEK 140.50
+17.3%
5.5%
SEK 150.00
SEK 129.00
n/a
6
Jun ’25
SEK 128.20
SEK 140.17
+9.3%
5.8%
SEK 150.00
SEK 129.00
n/a
6
May ’25
SEK 126.00
SEK 136.67
+8.5%
10.5%
SEK 150.00
SEK 108.00
n/a
6
Apr ’25
SEK 130.60
SEK 132.17
+1.2%
9.7%
SEK 147.00
SEK 108.00
n/a
6
Mar ’25
SEK 121.90
SEK 132.17
+8.4%
9.7%
SEK 147.00
SEK 108.00
n/a
6
Feb ’25
SEK 120.70
SEK 132.17
+9.5%
9.7%
SEK 147.00
SEK 108.00
n/a
6
Jan ’25
SEK 122.00
SEK 122.00
0%
6.6%
SEK 130.00
SEK 108.00
n/a
5
Dec ’24
SEK 109.20
SEK 120.60
+10.4%
6.7%
SEK 130.00
SEK 106.00
n/a
5
Nov ’24
SEK 99.55
SEK 120.60
+21.1%
6.7%
SEK 130.00
SEK 106.00
SEK 103.00
5
Oct ’24
SEK 97.15
SEK 122.80
+26.4%
7.8%
SEK 135.00
SEK 107.00
SEK 105.60
5
Sep ’24
SEK 106.90
SEK 122.80
+14.9%
7.8%
SEK 135.00
SEK 107.00
SEK 115.80
5
Aug ’24
SEK 113.90
SEK 122.80
+7.8%
7.8%
SEK 135.00
SEK 107.00
SEK 116.30
5
Jul ’24
SEK 114.30
SEK 126.20
+10.4%
8.7%
SEK 143.00
SEK 110.00
SEK 119.80
5
Jun ’24
SEK 111.20
SEK 126.20
+13.5%
8.7%
SEK 143.00
SEK 110.00
SEK 128.20
5
May ’24
SEK 120.70
SEK 124.00
+2.7%
9.3%
SEK 143.00
SEK 110.00
SEK 126.00
5
Apr ’24
SEK 128.50
SEK 123.40
-4.0%
8.5%
SEK 140.00
SEK 110.00
SEK 130.60
5
Mar ’24
SEK 117.40
SEK 116.75
-0.6%
3.5%
SEK 120.00
SEK 110.00
SEK 121.90
4
Feb ’24
SEK 114.90
SEK 116.75
+1.6%
3.5%
SEK 120.00
SEK 110.00
SEK 120.70
4
Jan ’24
SEK 111.10
SEK 124.25
+11.8%
9.7%
SEK 142.00
SEK 110.00
SEK 122.00
4
Dec ’23
SEK 114.70
SEK 122.25
+6.6%
9.8%
SEK 142.00
SEK 110.00
SEK 109.20
4
Nov ’23
SEK 109.00
SEK 121.75
+11.7%
10.3%
SEK 142.00
SEK 108.00
SEK 99.55
4
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.